Med Life SA (M) — Capital Reinvestment Ratio
Latest as of September 2025:
0.87x
Med Life SA (M) has a Capital Reinvestment Ratio of 0.87x as of September 2025, meaning it reinvests 1% of its operating cash flow (RON73.52 Million) in capital expenditures (RON63.89 Million). See M FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.87x
Capex / Operating Cash Flow
Operating Cash Flow
RON73.52 Million
RON
Capital Expenditures
RON63.89 Million
RON
Data as of
Sep 2025
Most recent filing
Med Life SA Capital Reinvestment Ratio (2020–2024)
This chart tracks Med Life SA's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Med Life SA (2020–2024)
Year-by-year Capital Reinvestment Ratio for Med Life SA from 2020 to 2024. For live market cap and broader valuation context, see M stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (RON) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.90x | RON276.31 Million | RON248.19 Million | ▼ -25.1% |
| 2023 | 1.20x | RON183.51 Million | RON219.96 Million | ▲ +30.7% |
| 2022 | 0.92x | RON184.62 Million | RON169.35 Million | ▲ +115.2% |
| 2021 | 0.43x | RON227.40 Million | RON96.91 Million | ▼ -38.4% |
| 2020 | 0.69x | RON128.66 Million | RON89.08 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow